Kim D Janda

Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions.

Neuropharmacology June 1, 2019 Jacques D. Nguyen, Yanabel Grant, Kevin M Creehan et al.

Growing nonmedical use of prescription opioids is a global problem, motivating research on ways to reduce use and combat addiction. Medical cannabis ("medical marijuana") legalization has been associated epidemiologically with reduced opioid harms and cannabinoids have been shown to modulate effects of opioids in animal models. This study was conducted to determine if Δ9-tetrahydrocannabinol...